San Francisco,17 October 2018:
According
to a report by Grand View Research, Inc., global controlled
release drug delivery market is anticipated to value USD 90.18
billion by 2025. Growing requirement for reduction in amount of drug dose and
dosage frequency to achieve prolonged therapeutic effect is anticipated to
propel demand for controlled release drug delivery system. These systems are
likely to offer multiple benefits over conventional medication delivery methods
such as fewer adverse gastrointestinal effects, uniform drug effect, and
enhanced patient compliance.
Rising R&D investments to
develop advanced drug delivery systems offering ease of medication
administration can influence growth of market. Growing need for controlled
release of medication dosage for geriatric and pediatric patients can spur
market growth. Growing adoption of systems that can deliver medication at
predetermined rate systematically or locally can augment growth of market
during the forecast period (2014 to 2025).
The controlled release drug
delivery market can be segregated on the basis of technology, release
mechanism, application, and region. Based on technology, the market can be
categorized into microencapsulation, wurster technique, implants, transdermal,
targeted delivery, coacervation, and others. Targeted delivery segment
dominated the market and accounted for largest market share in recent years. It
can help delivering medication to target site and can prevent toxicity by
keeping it away from other sites. In addition, it can bring uniform effect of
medication and reduce fluctuation in circulating drug levels.
Access
Research Report of Controlled
Release Drug Delivery Market@ www.grandviewresearch.com/industry-analysis/controlled-release-drug-delivery-market
On the contrary,
microencapsulation segment is likely to gain traction among consumers owing to
rising demand among companies over traditional drug delivery methods. It can
reduce toxicity and hence preferred among doctors for treatment of pediatric
and geriatric patients.
Based on release mechanism,
the market can be classified into feedback regulated drug delivery systems,
polymer matrix based systems, activation-modulated drug delivery systems, micro
reservoir partition controlled drug delivery systems, and chemically activated.
In 2016, polymer matrix based systems segment dominated the market and
accounted for largest market share owing to high demand. Ability to release
controlled and spatial release of loaded therapeutics coupled with their rate
dissolution can stimulate growth of segment.
Similarly, chemically
controlled systems segment can witness significant growth over the forecast
period. These systems can include hydrolysis activated systems, pH-activated
systems, and enzyme-responsive solutions.
Browse more reports of this category by
Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals
Based on application, the
market can be divided into metered dose inhalers, injectable, transdermal and
ocular patches, infusion pumps, oral controlled-drug delivery systems, and drug
eluting stents. In 2016, oral systems segment dominated the market and
accounted for largest market share attributed to frequent usage and
availability. In addition, these systems can offer targeted delivery and hence
preferred over conventional methods. Moreover, rising need for generic
medication is likely to create demand for oral drug delivery systems to limit
quantity of medicine used.
Similarly, metered dose
inhalers segment can also witness growth owing to its ability to administer
medication in controlled form using nanoparticles and polymeric materials.
Controlled release of drug to treat pulmonary disease can reduce frequency of
dosage by allowing medication to be delivered at desired site of action can
surge demand for metered dose inhalers.
Moreover, drug-eluting stents
can be used for treatment of several cardiac disorders.
Regional segmentation includes
Europe, North America, Asia Pacific, Latin America, and Middle East &
Africa. In 2016, North America dominated the market and accounted for largest
market share. Continual deployment of favorable government initiatives for
development of controlled release drug delivery coupled with rising investments
in R&D activities can fuel market growth. In addition, high prevalence of
leading market players in the region can augment growth of market. Moreover,
growing number of NDA and ANDA applications in the region coupled with rising
use of controlled release drug delivery systems by pharmaceutical companies can
stimulate market growth.
In Asia Pacific, the market is
expected to witness significant growth at highest CAGR over the forecast
period. Continual developments in pharmaceutical sector coupled with rising
R&D investments by multinational companies can influence growth of market.
In addition, liberal federal regulations and untapped market opportunities can
fuel market growth.
Some of the leading companies
offering controlled release drug delivery systems are Johnson and Johnson;
Corium International, Inc.; Alkermes plc; Orbis Biosciences, Inc.; and Aradigm
Corporation.
Access
Press Release of Controlled Release Drug Delivery Market@ www.grandviewresearch.com/press-release/global-controlled-release-drug-delivery-market
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
No comments:
Post a Comment